Philips Digital Pathology Solution Receives CE Mark for Diagnosis to Help Advance Oncology Diagnosis

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) has acquired the CE mark for diagnostic use of its Philips Digital Pathology Solution. European pathologists will now be able to use the full digital solution as an aid in diagnosis for routine pathology, such as primary diagnosis of oncology.

With the aging population and the increasing knowledge of the complexity of cancer cases, improving the efficiency and quality of cancer diagnostics has become a critical concern. By digitizing the images pathologists normally view through a microscope, Philips' solution offers high-quality images that could enable a more objective and quantitative diagnosis than currently possible. These digital images could also enable new ways to mine information from tumor tissue for further data analysis. Additionally, enhanced collaboration capabilities may speed up consults and second opinions which could improve diagnostic confidence.

"Pathologists play a critical role in the increasing demand for cancer diagnosis and care, and digital pathology looks promising in its ability to support faster, more confident diagnosis," said Perry van Rijsingen, General Manager of Philips Digital Pathology Solutions. "Helping improve workflows and collaboration could increase efficiency and productivity, and we believe that digitization will arm pathologists with the resources they need to successfully improve diagnostics."

The CE mark includes diagnosis for routine pathology including Hematoxylin and Eosin (H&E), Immunohistochemistry (IHC) and special stained tissue sections.

Through the Digital Pathology Solution, Philips strives to enable a faster and simplified pathology workflow and improved outcomes to make pathology labs more efficient. The digitization of pathology workflow is expected to ease logistical burdens and enables new ways of working, such as real-time collaboration between pathologists, the creation of virtual networks and the use of dedicated software tools.

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2013 sales of EUR 23.3 billion and employs approximately 113,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...